サンプル依頼リスト カート
  • English
  • Korean
表紙：鉄欠乏症用注射剤の世界市場レポート 2024年
市場調査レポート
商品コード
1415654

鉄欠乏症用注射剤の世界市場レポート 2024年

Iron Deficiency Injectable Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
鉄欠乏症用注射剤の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

鉄欠乏症用注射剤の市場規模は近年急速に拡大しています。2023年の127億5,000万米ドルから2024年には140億6,000万米ドルに、CAGR10.3％で拡大します。実績期間の成長は、鉄欠乏性貧血治療、肥満手術患者、小児・思春期患者、妊娠の増加に起因しています。

栄養不良のかなりの有病率は、鉄欠乏症用注射剤市場拡大の主要な促進要因です。栄養失調は、必須栄養素の摂取量と身体の栄養要求量の不均衡によって特徴づけられる健康状態を意味します。鉄欠乏症用注射剤は、鉄の貯蔵量を素早く補充し、血流に吸収されやすい鉄の濃縮量を供給することで、栄養不良の迅速な改善を可能にし、栄養不良に対処する上で重要な役割を果たします。例えば、2023年3月、カリフォルニア州公衆衛生局は、2022年の栄養失調に関連した死亡者数が1,406人に増加したと報告しました。その結果、栄養失調の有病率の高まりが鉄欠乏症用注射剤市場の今後の成長を促進すると予想されます。

2023年の鉄欠乏症用注射剤市場で最大の地域は北米でした。鉄欠乏症用注射剤レポートがカバーしている地域は、アジア太平洋、西欧、中東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年～2023年
  • 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

  • 世界の鉄欠乏症用注射剤市場、タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 鉄デキストラン
  • 鉄スクロース
  • カルボキシマルトース第二鉄
  • 世界の鉄欠乏症用注射剤市場、ブランドまたはジェネリック別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • ブランド
  • ジェネリック
  • 世界の鉄欠乏症用注射剤市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 慢性腎臓病
  • 炎症性腸疾患
  • がん
  • その他の用途
  • 世界の鉄欠乏症用注射剤市場、エンドユーザー別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院
  • ホームケア
  • 専門クリニック
  • その他のエンドユーザー

第7章 地域および国の分析

  • 世界の鉄欠乏症用注射剤市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界の鉄欠乏症用注射剤市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 鉄欠乏症用注射剤市場の競合情勢
  • 鉄欠乏症用注射剤市場の企業プロファイル
    • Daiichi Sankyo Company Limited
    • Pfizer Inc.
    • Aetna Inc.
    • AbbVie Inc.
    • Bayer AG

第31章 その他の主要および革新的な企業

  • Novartis AG
  • Sanofi S.A
  • AstraZeneca Plc
  • GSK Plc
  • Fresenius Medical Care
  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • B Braun Medical Inc.
  • Sandoz
  • Fresenius Kabi AG
  • Cipla Limited
  • Emcure Pharmaceuticals Ltd.
  • AMAG Pharmaceuticals Inc.
  • Luitpold Pharmaceuticals Inc.
  • Akebia Therapeutics Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r12253

“Iron Deficiency Injectable Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on iron deficiency injectable market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for iron deficiency injectable? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The iron deficiency injectable market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type: Iron Dextran; Iron Sucrose; Ferric Carboxymaltose
  • 2) By Branded or Generics: Branded; Generics
  • 3) By Application: Chronic Kidney Disease; Inflammatory Bowel Disease; Cancer; Other Applications
  • 4) By End User: Hospitals; Homecare; Specialty Clinics; Other End Users
  • Companies Mentioned: Daiichi Sankyo Company Limited; Pfizer Inc.; Aetna Inc.; AbbVie Inc.; Bayer AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Iron deficiency refers to a condition where the body lacks adequate iron, leading to decreased production of red blood cells and hemoglobin. Iron deficiency injectables refer to injectable medications or solutions used to treat iron deficiency. These injectable forms of iron allow for direct delivery of the iron into the bloodstream, bypassing the digestive system.

The main types of iron deficiency injectables are iron dextran, iron sucrose and ferric carboxymaltose. Iron dextran is a complex of iron and a carbohydrate called dextran. The various types of branded or generics are branded, generics that are used in various applications such as chronic kidney disease, inflammatory bowel disease, cancer and others and also by various end users such as hospitals, homecare, specialty clinics and others.

The iron deficiency injectables market research report is one of a series of new reports from The Business Research Company that provides iron deficiency injectables market statistics, including iron deficiency injectables industry global market size, regional shares, competitors with an iron deficiency injectables market share, detailed iron deficiency injectables market segments, market trends and opportunities and any further data you may need to thrive in the iron deficiency injectables industry. This iron deficiency injectables market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The iron deficiency injectable market size has grown rapidly in recent years. It will grow from $12.75 billion in 2023 to $14.06 billion in 2024 at a compound annual growth rate (CAGR) of 10.3%. The growth in the historic period can be attributed to high prevalence of iron deficiency anemia treatments, bariatric surgery patients, pediatric and adolescent patients, growing pregnancy.

The iron deficiency injectable market size is expected to see rapid growth in the next few years. It will grow to $20.68 billion in 2028 at a compound annual growth rate (CAGR) of 10.1%. The growth in the forecast period can be attributed to geriatric population, global health initiatives, government initiatives, incresing treatments for chronic conditions, rapid iron replenishment. Major trends in the forecast period include advances in iron formulations, digital health solutions, advancements in iron deficiency injectable therapy, adoption of iron-based drugs,.

The iron deficiency injectables market is anticipated to experience growth due to the increasing prevalence of polycystic ovary syndrome (PCOS). PCOS is a commonly occurring hormonal disorder that predominantly affects individuals with ovaries, primarily women in their reproductive years. PCOS often leads to iron overload, resulting in excessive menstrual bleeding and subsequent anemia in affected patients. Injectable iron deficiency medications offer an effective solution to address this condition. For example, as of June 2023, the World Health Organization, a specialized health agency based in the United States, estimates that PCOS affects approximately 8-13% of reproductive-aged women globally, with 70% of cases remaining undiagnosed. Hence, the rising prevalence of polycystic ovary syndrome (PCOS) serves as a driving force behind the growth of the iron deficiency injectables market.

The substantial prevalence of malnutrition is a key driver behind the expansion of the iron deficiency injectable market. Malnutrition signifies a health condition marked by an imbalance between the intake of essential nutrients and the nutritional requirements of the body. Iron deficiency injectables play a crucial role in addressing malnutrition by swiftly replenishing iron stores and delivering a concentrated dose of iron that is readily absorbed into the bloodstream, enabling the rapid correction of the deficiency. For example, in March 2023, the California Department of Public Health reported an increase in malnutrition-related deaths to 1,406 in 2022, marking a notable 22.36% surge compared to the 1,149 deaths recorded in 2021. As a result, the heightened prevalence of malnutrition is expected to drive the future growth of the iron deficiency injectable market.

The presence of alternative treatment options is a factor that may impede the growth of the iron deficiency injectables market in the forecast period. Alternative treatments encompass non-conventional approaches to addressing a medical condition. Conventional prescription drug therapies used for managing iron deficiency anemia include ferrous sulfate, erythropoietin (EPO) injections, and iron infusion therapy. For instance, as recommended by the American Metabolic and Bariatric Associations, oral administration remains the primary choice for treating patients with iron-deficiency anemia. Consequently, the availability of alternative treatments presents a challenge to the expansion of the market for iron deficiency injectables.

Prominent companies operating in the iron deficiency injectables market are actively engaged in the development of innovative therapies, such as INJECTAFER, to maintain their competitive standing in the market. For instance, in June 2023, Daiichi Sankyo Company, a U.S.-based healthcare company, in collaboration with American Regent Inc., a U.S.-based injectables manufacturer, introduced INJECTAFER (ferric carboxymaltose injection) for the treatment of iron deficiency. This innovative therapy received approval from the Food and Drug Administration (FDA), a U.S. government agency. INJECTAFER is recognized as the first and only intravenous iron replacement therapy approved for adult patients with chronic and progressive heart failure. It has undergone rigorous evaluation through more than 40 clinical trials involving over 8,800 participants from various countries, demonstrating its effectiveness in patients, including adults and pediatric individuals with iron-deficient anemia and heart failure.

In August 2022, CSL Limited, an Australian-based biotechnology company specializing in the production of iron deficiency injectables, completed the acquisition of Vifor Pharma for an undisclosed sum. This strategic acquisition reinforces CSL's commitment to patient care and enhances its capability to provide advanced medications. Vifor Pharma, headquartered in Switzerland, is a pharmaceutical company renowned for its offerings in the field of iron deficiency injectables.

Major players in the iron deficiency injectable market are Daiichi Sankyo Company Limited, Pfizer Inc., Aetna Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A, AstraZeneca PLC, GSK PLC, Fresenius Medical Care, Teva Pharmaceutical Industries Ltd., Mylan N.V., B Braun Medical Inc., Sandoz, Fresenius Kabi AG, Cipla Limited, Emcure Pharmaceuticals Ltd., AMAG Pharmaceuticals Inc., Luitpold Pharmaceuticals Inc., Akebia Therapeutics Inc., Covis Pharma GmbH , Keryx Biopharmaceuticals Inc., Rockwell Medical Inc., American Regent Inc., Galen Medical Group .

North America was the largest region in the iron deficiency injectable market in 2023. The regions covered in iron deficiency injectable report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the iron deficiency injectable market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The iron deficiency injectable market consists of sales of ferumoxide, sodium ferric gluconate and iron gluconate. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Iron Deficiency Injectable Market Characteristics

3. Iron Deficiency Injectable Market Trends And Strategies

4. Iron Deficiency Injectable Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Iron Deficiency Injectable Market Size and Growth

  • 5.1. Global Iron Deficiency Injectable Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Iron Deficiency Injectable Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Iron Deficiency Injectable Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Iron Deficiency Injectable Market Segmentation

  • 6.1. Global Iron Deficiency Injectable Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Iron Dextran
  • Iron Sucrose
  • Ferric Carboxymaltose
  • 6.2. Global Iron Deficiency Injectable Market, Segmentation By Branded or Generics, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Branded
  • Generics
  • 6.3. Global Iron Deficiency Injectable Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Chronic Kidney Disease
  • Inflammatory Bowel Disease
  • Cancer
  • Other Applications
  • 6.4. Global Iron Deficiency Injectable Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Homecare
  • Specialty Clinics
  • Other End Users

7. Iron Deficiency Injectable Market Regional And Country Analysis

  • 7.1. Global Iron Deficiency Injectable Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Iron Deficiency Injectable Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Iron Deficiency Injectable Market

  • 8.1. Asia-Pacific Iron Deficiency Injectable Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Iron Deficiency Injectable Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Iron Deficiency Injectable Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Iron Deficiency Injectable Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Iron Deficiency Injectable Market

  • 9.1. China Iron Deficiency Injectable Market Overview
  • 9.2. China Iron Deficiency Injectable Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Iron Deficiency Injectable Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Iron Deficiency Injectable Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Iron Deficiency Injectable Market

  • 10.1. India Iron Deficiency Injectable Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Iron Deficiency Injectable Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Iron Deficiency Injectable Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Iron Deficiency Injectable Market

  • 11.1. Japan Iron Deficiency Injectable Market Overview
  • 11.2. Japan Iron Deficiency Injectable Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Iron Deficiency Injectable Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Iron Deficiency Injectable Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Iron Deficiency Injectable Market

  • 12.1. Australia Iron Deficiency Injectable Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Iron Deficiency Injectable Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Iron Deficiency Injectable Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Iron Deficiency Injectable Market

  • 13.1. Indonesia Iron Deficiency Injectable Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Iron Deficiency Injectable Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Iron Deficiency Injectable Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Iron Deficiency Injectable Market

  • 14.1. South Korea Iron Deficiency Injectable Market Overview
  • 14.2. South Korea Iron Deficiency Injectable Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Iron Deficiency Injectable Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Iron Deficiency Injectable Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Iron Deficiency Injectable Market

  • 15.1. Western Europe Iron Deficiency Injectable Market Overview
  • 15.2. Western Europe Iron Deficiency Injectable Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Iron Deficiency Injectable Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Iron Deficiency Injectable Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Iron Deficiency Injectable Market

  • 16.1. UK Iron Deficiency Injectable Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Iron Deficiency Injectable Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Iron Deficiency Injectable Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Iron Deficiency Injectable Market

  • 17.1. Germany Iron Deficiency Injectable Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Iron Deficiency Injectable Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Iron Deficiency Injectable Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Iron Deficiency Injectable Market

  • 18.1. France Iron Deficiency Injectable Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Iron Deficiency Injectable Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Iron Deficiency Injectable Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Iron Deficiency Injectable Market

  • 19.1. Italy Iron Deficiency Injectable Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Iron Deficiency Injectable Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Iron Deficiency Injectable Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Iron Deficiency Injectable Market

  • 20.1. Spain Iron Deficiency Injectable Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Iron Deficiency Injectable Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Iron Deficiency Injectable Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Iron Deficiency Injectable Market

  • 21.1. Eastern Europe Iron Deficiency Injectable Market Overview
  • 21.2. Eastern Europe Iron Deficiency Injectable Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Iron Deficiency Injectable Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Iron Deficiency Injectable Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Iron Deficiency Injectable Market

  • 22.1. Russia Iron Deficiency Injectable Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Iron Deficiency Injectable Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Iron Deficiency Injectable Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Iron Deficiency Injectable Market

  • 23.1. North America Iron Deficiency Injectable Market Overview
  • 23.2. North America Iron Deficiency Injectable Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Iron Deficiency Injectable Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Iron Deficiency Injectable Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Iron Deficiency Injectable Market

  • 24.1. USA Iron Deficiency Injectable Market Overview
  • 24.2. USA Iron Deficiency Injectable Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Iron Deficiency Injectable Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Iron Deficiency Injectable Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Iron Deficiency Injectable Market

  • 25.1. Canada Iron Deficiency Injectable Market Overview
  • 25.2. Canada Iron Deficiency Injectable Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Iron Deficiency Injectable Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Iron Deficiency Injectable Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Iron Deficiency Injectable Market

  • 26.1. South America Iron Deficiency Injectable Market Overview
  • 26.2. South America Iron Deficiency Injectable Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Iron Deficiency Injectable Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Iron Deficiency Injectable Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Iron Deficiency Injectable Market

  • 27.1. Brazil Iron Deficiency Injectable Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Iron Deficiency Injectable Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Iron Deficiency Injectable Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Iron Deficiency Injectable Market

  • 28.1. Middle East Iron Deficiency Injectable Market Overview
  • 28.2. Middle East Iron Deficiency Injectable Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Iron Deficiency Injectable Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Iron Deficiency Injectable Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Iron Deficiency Injectable Market

  • 29.1. Africa Iron Deficiency Injectable Market Overview
  • 29.2. Africa Iron Deficiency Injectable Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Iron Deficiency Injectable Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Iron Deficiency Injectable Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Iron Deficiency Injectable Market Competitive Landscape And Company Profiles

  • 30.1. Iron Deficiency Injectable Market Competitive Landscape
  • 30.2. Iron Deficiency Injectable Market Company Profiles
    • 30.2.1. Daiichi Sankyo Company Limited
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Pfizer Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Aetna Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. AbbVie Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Bayer AG
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Iron Deficiency Injectable Market Other Major And Innovative Companies

  • 31.1. Novartis AG
  • 31.2. Sanofi S.A
  • 31.3. AstraZeneca Plc
  • 31.4. GSK Plc
  • 31.5. Fresenius Medical Care
  • 31.6. Teva Pharmaceutical Industries Ltd.
  • 31.7. Mylan N.V.
  • 31.8. B Braun Medical Inc.
  • 31.9. Sandoz
  • 31.10. Fresenius Kabi AG
  • 31.11. Cipla Limited
  • 31.12. Emcure Pharmaceuticals Ltd.
  • 31.13. AMAG Pharmaceuticals Inc.
  • 31.14. Luitpold Pharmaceuticals Inc.
  • 31.15. Akebia Therapeutics Inc.

32. Global Iron Deficiency Injectable Market Competitive Benchmarking

33. Global Iron Deficiency Injectable Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Iron Deficiency Injectable Market

35. Iron Deficiency Injectable Market Future Outlook and Potential Analysis

  • 35.1 Iron Deficiency Injectable Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Iron Deficiency Injectable Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Iron Deficiency Injectable Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer